+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid

Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid

Folia Medica 42(3): 16-19

Possible drug interactions in comedication have been the focus of intensive studies in the last decade. Polytherapy is often resorted to in epilepsy, and then the effect of factors such as gender, age, and metabolism should be taken into consideration. In this country, the anticonvulsant drugs used very frequently in a combined treatment of epilepsy are carbamazepine (CBZ) and valproic acid (VPA). The effect of CBZ is determined by the presence of its active metabolite carbamazepine-10.11-epoxide (CBZ-E) in blood serum. The purpose of the study was to find whether CBZ-E has any effect on the VPA serum level and whether this effect is age-dependent. Blood samples from 52 epileptic patients on comedication with CBZ and VPA aged 3 to 53 years were examined. The patients were allocated into four age groups: preschool age (from 3 to 6 years)--9 patients; school age (from 7 to 14 years)--8 patients; adolescence (from 15 to 18 years)--11 patients, and adults (from 19 to 53 years)--24 patients. The serum levels of CBZ, CBZ-E, VPA were determined by gas chromatography. The ratio CBZ-E/CBZ of every patient was calculated. The CBZ and VPA levels we found were within the limits of their respective therapeutic ranges. The mean values of the serum level of the two drugs showed no statistically significant difference in the four age groups. In the school age group the mean values of CBZ and VPA were the lowest compared to the other age groups. The effect of CBZ-E serum level upon VPA serum level is age-dependent. In preschool age VPA manifests itself as inhibitor of CBZ-E metabolism. The ratio CBZ-E/CBZ does not affect the VPA serum level in combined therapy with these two drugs.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046396842

Download citation: RISBibTeXText

PMID: 11347330

Related references

Prediction of the free serum concentrations of phenytoin phenobarbital carbamazepine and carbamazepine 10 11 epoxide in patients on valproic acid co medication. Sunshine, I (Ed ) Recent Developments in Therapeutic Drug Monitoring And Clinical Toxicology; Second International Conference on Tdm (Therapeutic Drug Monitoring)-Toxicology, Barcelona, Spain Xii+791p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 401-407, 1992

Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine. British Journal of Clinical Pharmacology 29(6): 759-762, 1990

Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs. Epilepsy Research 122: 84-90, 2016

Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?. Therapeutic Drug Monitoring 17(3): 217-220, 1995

Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid. International Journal of Clinical Pharmacology Research 9(1): 55-58, 1989

Inhibitory effect of valproic acid on the disposition of carbamazepine and carbamazepine-10,11-epoxide in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(3): 281-286, 1986

Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. Journal of Child Neurology 13(11): 546-549, 1998

Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurologica Scandinavica 83(4): 250-253, 1991

Interaction between valproic acid and carbamazepine in epileptic patients. Levy, R H Et Al (Ed ) Metabolism Of Antiepileptic Drugs; Workshop, Phoenix, Ariz , Usa Xvii+245p Raven Press: New York, N Y , Usa Illus P45-52, 1984

Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine. Brain and Development 26(1): 15-18, 2004

Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients. Journal of the College of Physicians and Surgeons--Pakistan 28(5): 357-360, 2018

The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity. Journal of Child Neurology 26(12): 1522-1524, 2012

Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital. Journal of Child Neurology 21(1): 48-53, 2006

Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid. Epilepsia 51(2): 312-315, 2010

Pharmacokinetic interaction between valproic acid, topiramate, phenytoin or carbamazepine and retigabine in epileptic patients. Clinical Pharmacology & Therapeutics 69(2): P18, 2001